Unlock access to every one of the hundreds of articles published daily on BroadwayWorld by logging in with one click. APOLLO AND THE TRIALS OF HERCULES is a new play by First Stage Resident Playwright ...
Medical experts discuss the failure of evobrutinib to meet its primary endpoint in phase 3 trials, review the primary outcomes of the phase 2B study of tolebrutinib in relapsing multiple sclerosis, ...
COPENHAGEN, Denmark — A new investigational drug has become the first agent to slow disability in patients with nonrelapsing secondary progressive multiple sclerosis (nrSPMS). The Phase 3 HERCULES ...
WEST PALM BEACH, FLORIDA — A new post hoc analysis of three phase 3 multiple sclerosis (MS) trials in patients with paramagnetic rim lesions (PRLs) suggests that a central nervous system ...
Tuesday, April 8, 2025, Cleveland: A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton’s tyrosine kinase inhibitor, a group of drugs originally developed to treat ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Investigational ...
New evidence added to the literature that paramagnetic rim lesions (PRLs) may be a biomarker of disability accumulation in multiple sclerosis (MS). PRLs are thought to capture a subset of chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback